Genetic adaptation of achromobacter sp. during persistence in the lungs of cystic fibrosis patients

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Ridderberg, Winnie ^a   Nielsen, Signe Maria ^a,b   Nørskov Lauritsen, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACHROMOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL FLAGELLUM; BACTERIAL GENOME; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM PILUS; CLINICAL ARTICLE; CYSTIC FIBROSIS; DNA BASE COMPOSITION; EVOLUTIONARY ADAPTATION; GENE DELETION; GENE SEQUENCE; GRAM NEGATIVE INFECTION; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; TYPE I SECRETION SYSTEM; TYPE III SECRETION SYSTEM; ADAPTATION; CELL WALL; EVOLUTION; FIMBRIA; GENETICS; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY;

BACTERIAL PROTEIN;

ACHROMOBACTER; ADAPTATION, BIOLOGICAL; BACTERIAL PROTEINS; BIOLOGICAL EVOLUTION; CELL WALL; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FIMBRIAE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LONGITUDINAL STUDIES; MUTATION;

EID: 84942859393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136790     Document Type: Article

References (77)

1. Yabuuchi E, Kawamura Y, Kosako Y, Ezaki T. Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Ruger and Tan) comb. nov. Microbiology and immunology. 1998; 42(6):429-38. PMID: 9688077.
2. Amoureux L, Bador J, Siebor E, Taillefumier N, Fanton A, Neuwirth C. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society. 2013; 12(2):170-6. doi: 10. 1016/j.jcf.2012.08.005 PMID: 22944724.
3. Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatric pulmonology. 2010; 45(4):363-70. doi: 10. 1002/ppul.21198 PMID: 20232473.
4. Ridderberg W, Bendstrup KE, Olesen HV, Jensen-Fangel S, Norskov-Lauritsen N. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society. 2011; 10 (6):466-9. doi: 10.1016/j.jcf.2011.07.004 PMID: 21835703.
5. Kanellopoulou M, Pournaras S, Iglezos H, Skarmoutsou N, Papafrangas E, Maniatis AN. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2004; 23(4):336-9. doi: 10.1007/s10096-004-1105-9 PMID: 15024624.
6. Krzewinski JW, Nguyen CD, Foster JM, Burns JL. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. Journal of clinical microbiology. 2001; 39(10):3597-602. doi: 10. 1128/JCM.39.10.3597-3602.2001 PMID: 11574579; PubMed Central PMCID: PMC88395.
7. Lambiase A, Catania MR, Del Pezzo M, Rossano F, Terlizzi V, Sepe A, et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2011; 30 (8):973-80. doi: 10.1007/s10096-011-1182-5 PMID: 21279730; PubMed Central PMCID: PMC3132409.
8. Goerke C, Wolz C. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. International journal of medical microbiology: IJMM. 2010; 300(8):520-5. doi: 10.1016/j.ijmm.2010.08.003 PMID: 20843740.
9. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology. 2007; 153(Pt 4):917-23. doi: 10. 1099/mic.0.2006/004077-0 PMID: 17379702.
10. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. American journal of respiratory and critical care medicine. 2009; 180(2):138-45. doi: 10.1164/rccm.200812-1943OC PMID: 19423715.
11. Hirschhausen N, Block D, Bianconi I, Bragonzi A, Birtel J, Lee JC, et al. Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation. International journal of medical microbiology: IJMM. 2013; 303(8):685-92. doi: 10.1016/j.ijmm.2013.09.012 PMID: 24183484.
12. McAdam PR, Holmes A, Templeton KE, Fitzgerald JR. Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PloS one. 2011; 6(9):e24301. doi: 10. 1371/journal.pone.0024301 PMID: 21912685; PubMed Central PMCID: PMC3166311.
13. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(22):8487-92. doi: 10.1073/pnas. 0602138103 PMID: 16687478; PubMed Central PMCID: PMC1482519.
14. Darch SE, McNally A, Harrison F, Corander J, Barr HL, Paszkiewicz K, et al. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Scientific reports. 2015; 5:7649. doi: 10.1038/srep07649 PMID: 25578031; PubMed Central PMCID: PMC4289893.
15. Ridderberg W, Wang M, Norskov-Lauritsen N. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. Journal of clinical microbiology. 2012; 50(8):2688-94. doi: 10.1128/JCM.00728-12 PMID: 22675125; PubMed Central PMCID: PMC3421494.
16. Spilker T, Vandamme P, Lipuma JJ. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. Journal of clinical microbiology. 2012; 50 (9):3010-5. doi: 10.1128/JCM.00814-12 PMID: 22785192; PubMed Central PMCID: PMC3421806.
17. Turabelidze D, Kotetishvili M, Kreger A, Morris JG Jr., Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. Journal of clinical microbiology. 2000; 38 (11):4242-5. Epub 2000/11/04. PMID: 11060099; PubMed Central PMCID: PMC87572.
18. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of clinical microbiology. 1995; 33(9):2233-9. Epub 1995/09/01. PMID: 7494007; PubMed Central PMCID: PMC228385.
19. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST Server: rapid annotations using subsystems technology. BMC genomics. 2008; 9:75. doi: 10.1186/1471-2164-9-75 PMID: 18261238; PubMed Central PMCID: PMC2265698.
20. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, et al. The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic acids research. 2014; 42 (Database issue):D206-14. doi: 10.1093/nar/gkt1226 PMID: 24293654; PubMed Central PMCID: PMC3965101.
21. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. doi: 10.1093/bioinformatics/btp324 PMID: 19451168; PubMed Central PMCID: PMC2705234.
22. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114-20. doi: 10.1093/bioinformatics/btu170 PMID: 24695404; PubMed Central PMCID: PMC4103590.
23. Rimmer A, Phan H, Mathieson I, Iqbal Z, Twigg SR, Consortium WGS, et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nature genetics. 2014; 46(8):912-8. doi: 10.1038/ng.3036 PMID: 25017105.
24. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics. 2009; 25 (21):2865-71. doi: 10.1093/bioinformatics/btp394 PMID: 19561018; PubMed Central PMCID: PMC2781750.
25. Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012; 6(2):80-92. doi: 10.4161/fly.19695 PMID: 22728672; PubMed Central PMCID: PMC3679285.
26. Cingolani P, Patel VM, Coon M, Nguyen T, Land SJ, Ruden DM, et al. Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift. Frontiers in genetics. 2012; 3:35. doi: 10.3389/fgene.2012.00035 PMID: 22435069; PubMed Central PMCID: PMC3304048.
27. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PloS one. 2012; 7(10):e46688. doi: 10.1371/journal.pone.0046688 PMID: 23056405; PubMed Central PMCID: PMC3466303.
28. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, et al. Artemis: sequence visualization and annotation. Bioinformatics. 2000; 16(10):944-5. PMID: 11120685.
29. O'Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;(47: ). doi: 10.3791/2437 PMID: 21307833; PubMed Central PMCID: PMC3182663.
30. Harrison JJ, Stremick CA, Turner RJ, Allan ND, Olson ME, Ceri H. Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nat Protoc. 2010; 5(7):1236-54. doi: 10.1038/nprot.2010.71 PMID: 20595953.
31. Barth AL, Pitt TL. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. Journal of clinical microbiology. 1995; 33(8):2192-4. PMID: 7559977; PubMed Central PMCID: PMC228364.
32. Hu Y, Zhu Y, Ma Y, Liu F, Lu N, Yang X, et al. Genomic insights into the intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans. Antimicrobial agents and chemotherapy. 2014. doi: 10.1128/AAC.04260-14 PMID: 25487802.
33. Jakobsen TH, Hansen MA, Jensen PO, Hansen L, Riber L, Cockburn A, et al. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PloS one. 2013; 8(7):e68484. doi: 10.1371/journal.pone.0068484 PMID: 23894309; PubMed Central PMCID: PMC3718787.
34. Dunn MF, Niks D, Ngo H, Barends TR, Schlichting I. Tryptophan synthase: the workings of a channeling nanomachine. Trends in biochemical sciences. 2008; 33(6):254-64. doi: 10.1016/j.tibs.2008.04. 008 PMID: 18486479.
35. Ramakrishnan T, Adelberg EA. Regulatory Mechanisms in the Biosynthesis of Isoleucine and Valine. I. Genetic Derepression of Enzyme Formation. Journal of bacteriology. 1964; 87:566-73. PMID: 14127571; PubMed Central PMCID: PMC277055.
36. Clausen T, Huber R, Prade L, Wahl MC, Messerschmidt A. Crystal structure of Escherichia coli cystathionine gamma-synthase at 1.5 A resolution. The EMBO journal. 1998; 17(23):6827-38. doi: 10. 1093/emboj/17.23.6827 PMID: 9843488; PubMed Central PMCID: PMC1171030.
37. Kikuchi G, Motokawa Y, Yoshida T, Hiraga K. Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proceedings of the Japan Academy Series B, Physical and biological sciences. 2008; 84(7):246-63. PMID: 18941301; PubMed Central PMCID: PMC3666648.
38. Grant GA, Schuller DJ, Banaszak LJ. A model for the regulation of D-3-phosphoglycerate dehydrogenase, a Vmax-type allosteric enzyme. Protein science: a publication of the Protein Society. 1996; 5 (1):34-41. doi: 10.1002/pro.5560050105 PMID: 8771194; PubMed Central PMCID: PMC2143248.
39. Carpenter EP, Hawkins AR, Frost JW, Brown KA. Structure of dehydroquinate synthase reveals an active site capable of multistep catalysis. Nature. 1998; 394(6690):299-302. doi: 10.1038/28431 PMID: 9685163.
40. Thomas SR, Ray A, Hodson ME, Pitt TL. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax. 2000; 55(9):795-7. PMID: 10950901; PubMed Central PMCID: PMC1745865.
41. Chrysostomou C, Quandt EM, Marshall NM, Stone E, Georgiou G. An Alternate Pathway of Arsenate Resistance in E. coli Mediated by the Glutathione S-Transferase GstB. ACS chemical biology. 2015. doi: 10.1021/cb500755j PMID: 25517993.
42. Negoro S. Biodegradation of nylon oligomers. Applied microbiology and biotechnology. 2000; 54 (4):461-6. PMID: 11092619.
43. Majdalani N, Gottesman S. The Rcs phosphorelay: a complex signal transduction system. Annual review of microbiology. 2005; 59:379-405. doi: 10.1146/annurev.micro.59.050405.101230 PMID: 16153174.
44. Nivens DE, Ohman DE, Williams J, Franklin MJ. Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. Journal of bacteriology. 2001; 183(3):1047-57. doi: 10.1128/JB.183.3.1047-1057.2001 PMID: 11208804; PubMed Central PMCID: PMC94973.
45. Zhuo C, Zhao QY, Xiao SN. The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia. PloS one. 2014; 9(10):e108409. doi: 10.1371/journal.pone.0108409 PMID: 25285537; PubMed Central PMCID: PMC4186781.
46. Huang TP, Somers EB, Wong AC. Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia. Journal of bacteriology. 2006; 188(8):3116-20. doi: 10.1128/JB.188.8.3116-3120.2006 PMID: 16585771; PubMed Central PMCID: PMC1446987.
47. Graninger M, Nidetzky B, Heinrichs DE, Whitfield C, Messner P. Characterization of dTDP-4-dehydrorhamnose 3,5-epimerase and dTDP-4-dehydrorhamnose reductase, required for dTDP-L-rhamnose biosynthesis in Salmonella enterica serovar Typhimurium LT2. The Journal of biological chemistry. 1999; 274(35):25069-77. PMID: 10455186.
48. Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infection and immunity. 1994; 62(2):596-605. PMID: 8300217; PubMed Central PMCID: PMC186146.
49. Wang M, Ridderberg W, Hansen CR, Hoiby N, Jensen-Fangel S, Olesen HV, et al. Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society. 2013; 12(6):638-43. doi: 10.1016/j.jcf. 2013.04.013 PMID: 23727271.
50. Bador J, Amoureux L, Blanc E, Neuwirth C. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrobial agents and chemotherapy. 2013; 57(1):603-5. doi: 10.1128/AAC.01243-12 PMID: 23089757; PubMed Central PMCID: PMC3535963.
51. Bador J, Amoureux L, Duez JM, Drabowicz A, Siebor E, Llanes C, et al. First description of an RNDtype multidrug efflux pump in Achromobacter xylosoxidans, AxyABM. Antimicrobial agents and chemotherapy. 2011; 55(10):4912-4. doi: 10.1128/AAC.00341-11 PMID: 21807978; PubMed Central PMCID: PMC3186983.
52. Doi Y, Poirel L, Paterson DL, Nordmann P. Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Antimicrobial agents and chemotherapy. 2008; 52(6):1952-6. doi: 10.1128/AAC.01463-07 PMID: 18362192; PubMed Central PMCID: PMC2415784.
53. Zeng X, Lin J. Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. Frontiers in microbiology. 2013; 4:128. doi: 10.3389/fmicb.2013.00128 PMID: 23734147; PubMed Central PMCID: PMC3660660.
54. Grkovic S, Brown MH, Skurray RA. Regulation of bacterial drug export systems. Microbiology and molecular biology reviews: MMBR. 2002; 66(4):671-701, table of contents. PMID: 12456787; PubMed Central PMCID: PMC134658.
55. Escamilla-Hernandez R, O'Brian MR. HmuP is a coactivator of Irr-dependent expression of heme utilization genes in Bradyrhizobium japonicum. Journal of bacteriology. 2012; 194(12):3137-43. doi: 10. 1128/JB.00071-12 PMID: 22505680; PubMed Central PMCID: PMC3370842.
56. Ochsner UA, Johnson Z, Vasil ML. Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa. Microbiology. 2000; 146 (Pt 1):185-98. PMID: 10658665.
57. Thompson JM, Jones HA, Perry RD. Molecular characterization of the hemin uptake locus (hmu) from Yersinia pestis and analysis of hmu mutants for hemin and hemoprotein utilization. Infection and immunity. 1999; 67(8):3879-92. PMID: 10417152; PubMed Central PMCID: PMC96668.
58. Skaar EP. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS pathogens. 2010; 6(8):e1000949. doi: 10.1371/journal.ppat.1000949 PMID: 20711357; PubMed Central PMCID: PMC2920840.
59. Gao Q, Wang X, Xu H, Xu Y, Ling J, Zhang D, et al. Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model. BMC microbiology. 2012; 12:143. doi: 10.1186/1471-2180-12-143 PMID: 22817680; PubMed Central PMCID: PMC3496646.
60. Ricci V, Giannouli M, Romano M, Zarrilli R. Helicobacter pylori gamma-glutamyl transpeptidase and its pathogenic role. World journal of gastroenterology: WJG. 2014; 20(3):630-8. doi: 10.3748/wjg.v20.i3. 630 PMID: 24574736; PubMed Central PMCID: PMC3921472.
61. Wunsch P, Zumft WG. Functional domains of NosR, a novel transmembrane iron-sulfur flavoprotein necessary for nitrous oxide respiration. Journal of bacteriology. 2005; 187(6):1992-2001. doi: 10.1128/ JB.187.6.1992-2001.2005 PMID: 15743947; PubMed Central PMCID: PMC1064061.
62. Hodgkinson V, Petris MJ. Copper homeostasis at the host-pathogen interface. The Journal of biological chemistry. 2012; 287(17):13549-55. doi: 10.1074/jbc.R111.316406 PMID: 22389498; PubMed Central PMCID: PMC3340201.
63. Hinsa SM, Espinosa-Urgel M, Ramos JL, O'Toole GA. Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescens WCS365 requires an ABC transporter and a large secreted protein. Molecular microbiology. 2003; 49(4):905-18. PMID: 12890017.
64. Costa TR, Edqvist PJ, Broms JE, Ahlund MK, Forsberg A, Francis MS. YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis. The Journal of biological chemistry. 2010; 285(33):25269-84. doi: 10.1074/jbc.M110.144311 PMID: 20525687; PubMed Central PMCID: PMC2919090.
65. Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Current opinion in microbiology. 2009; 12(1):61-6. doi: 10.1016/j.mib.2008.12.007 PMID: 19168385.
66. Haralalka S, Nandi S, Bhadra RK. Mutation in the relA gene of Vibrio cholerae affects in vitro and in vivo expression of virulence factors. Journal of bacteriology. 2003; 185(16):4672-82. PMID: 12896985; PubMed Central PMCID: PMC166452.
67. Jin W, Ryu YG, Kang SG, Kim SK, Saito N, Ochi K, et al. Two relA/spoT homologous genes are involved in the morphological and physiological differentiation of Streptomyces clavuligerus. Microbiology. 2004; 150(Pt 5):1485-93. PMID: 15133110.
68. Miyazaki E, Chen JM, Ko C, Bishai WR. The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB. Journal of bacteriology. 1999; 181(9):2846-51. PMID: 10217777; PubMed Central PMCID: PMC93728.
69. van Schaik W, Abee T. The role of sigmaB in the stress response of Gram-positive bacteria-targets for food preservation and safety. Current opinion in biotechnology. 2005; 16(2):218-24. doi: 10.1016/j. copbio.2005.01.008 PMID: 15831390.
70. Ballal A, Basu B, Apte SK. The Kdp-ATPase system and its regulation. Journal of biosciences. 2007; 32(3):559-68. PMID: 17536175.
71. Brandon L, Dorus S, Epstein W, Altendorf K, Jung K. Modulation of KdpD phosphatase implicated in the physiological expression of the kdp ATPase of Escherichia coli. Molecular microbiology. 2000; 38 (5):1086-92. PMID: 11123681.
72. Cotter PA, Chepuri V, Gennis RB, Gunsalus RP. Cytochrome o (cyoABCDE) and d (cydAB) oxidase gene expression in Escherichia coli is regulated by oxygen, pH, and the fnr gene product. Journal of bacteriology. 1990; 172(11):6333-8. PMID: 2172211; PubMed Central PMCID: PMC526817.
73. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends in microbiology. 2009; 17(3):130-8. doi: 10.1016/j.tim.2008.12.003 PMID: 19231190.
74. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, et al. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. Journal of bacteriology. 2008; 190(24):7910-7. doi: 10.1128/JB.01147-08 PMID: 18849421; PubMed Central PMCID: PMC2593214.
75. Prunier AL, Malbruny B, Laurans M, Brouard J, Duhamel JF, Leclercq R. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. The Journal of infectious diseases. 2003; 187(11):1709-16. doi: 10.1086/ 374937 PMID: 12751028.
76. Watson ME Jr, Burns JL, Smith AL. Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology. 2004; 150(Pt 9):2947-58. doi: 10.1099/mic.0.27230-0 PMID: 15347753.
77. Miller JH. Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. Annual review of microbiology. 1996; 50:625-43. doi: 10.1146/annurev.micro.50.1.625 PMID: 8905093.